Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$6.78 - $8.1 $9.4 Million - $11.2 Million
1,386,000 Added 15.1%
10,563,748 $76.8 Million
Q4 2022

Feb 14, 2023

BUY
$5.72 - $9.78 $20.5 Million - $35.1 Million
3,587,700 Added 64.18%
9,177,748 $66.9 Million
Q3 2022

Nov 14, 2022

BUY
$7.24 - $10.31 $16.1 Million - $22.9 Million
2,222,222 Added 65.98%
5,590,048 $43.2 Million
Q1 2022

May 16, 2022

BUY
$5.46 - $8.13 $2.44 Million - $3.64 Million
447,300 Added 15.32%
3,367,826 $26.8 Million
Q4 2021

Feb 14, 2022

BUY
$4.83 - $9.75 $716,289 - $1.45 Million
148,300 Added 5.35%
2,920,526 $16.4 Million
Q3 2021

Nov 15, 2021

BUY
$7.42 - $11.26 $20.6 Million - $31.2 Million
2,772,226 New
2,772,226 $21.3 Million

Others Institutions Holding PNT

# of Institutions
1
Shares Held
20K
Call Options Held
0
Put Options Held
0

About POINT Biopharma Global Inc.


  • Ticker PNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,025,000
  • Description
  • POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...
More about PNT
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.